http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14055780

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Comparative Study|Journal Article|Randomized Controlled Trial
endingPage 1907
issn 0735-1097
issueIdentifier 19
pageRange 1899-1907
publicationName Journal of the American College of Cardiology
startingPage 1899
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f8ceaaae81bcb5de79d5c845e89a4fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f002a103a640f8e7962374e1ea7f8a81
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_25398f0fd8013e6d077f0879d66d25e4
bibliographicCitation Voors AA, Dittrich HC, Massie BM, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol. 2011 May 10;57(19):1899–907. doi: 10.1016/j.jacc.2010.11.057. PMID: 21545947.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3391-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2cc2529320cda9c2712f9c7c3afd544
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6328044750551149b282e681b64c49f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9613-3339
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9d8ceba630c0386d67fd4e4ed4a1e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_042e1a5cde060be70bdaee38ca93ad96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d06ca4d19acd76f1d21f9711633f1a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ac48351283810ff3b9a765b3c35697b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fb155addda319f571f5931ee0783353
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a004926d26d55c91303ea5cceb197a71
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_872b0380f8a7d6c43c91004f8cc0f1f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0de5927d23176a640d3a88a180115966
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efb573f36e9de05ec03a449053ed9de1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa0ece3d08af7bea756a54ad74c863a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f993379f90966f59f13d94acab48397
date 2011-05-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1016/j.jacc.2010.11.057
https://pubmed.ncbi.nlm.nih.gov/21545947
isPartOf https://portal.issn.org/resource/ISSN/0735-1097
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
discusses http://id.nlm.nih.gov/mesh/M0023046
http://id.nlm.nih.gov/mesh/M0198780
http://id.nlm.nih.gov/mesh/M0545363
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D006760
http://id.nlm.nih.gov/mesh/D007668Q000187
http://id.nlm.nih.gov/mesh/D006333Q000188
http://id.nlm.nih.gov/mesh/D058916Q000627
http://id.nlm.nih.gov/mesh/D014970Q000627
http://id.nlm.nih.gov/mesh/D007674Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000208
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D058916Q000494
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D014970Q000494
http://id.nlm.nih.gov/mesh/D007668Q000502
http://id.nlm.nih.gov/mesh/D006333Q000503
http://id.nlm.nih.gov/mesh/D006333Q000150
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D007674Q000150
http://id.nlm.nih.gov/mesh/D013318Q000502
http://id.nlm.nih.gov/mesh/D013318Q000187
http://id.nlm.nih.gov/mesh/D007674Q000503
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010865
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11948288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64627
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8af6e28266b87d98896ed68323766b3b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128923271

Showing number of triples: 1 to 70 of 70.